Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Glucose Monitoring Dec 06 | 2018CGM: Novel Non-invasive Platform Similar To Libre CGM DataPurchase Blast$599
Posted in: Other Dec 05 | 2018Sanofi cuts ~670 jobs and adds 250 employees in FrancePurchase Blast$599
Posted in: Bolus Insulin, Insulin Delivery Dec 04 | 2018New Mylan and Lilly trials: Ph3 biosimilar insulin aspart study, Ph2 URLi study in 670GPurchase Blast$599
Posted in: SGLT2i Nov 30 | 2018Nothing New in Sota Adcom Federal Register AnnouncementPurchase Blast$599
Posted in: SGLT2i Nov 29 | 2018Sotagliflozin Adcom in T1DM Scheduled for January 17, 2019Purchase Blast$599
Posted in: Basal Insulin Nov 28 | 2018New Novo Ph2 study for QW Insulin 287 in T2DMPurchase Blast$599
Posted in: GLP-1RA, SGLT2i Nov 27 | 2018Thoughts on New ACC T2DM ASCVD RecommendationsPurchase Blast$599
Posted in: SGLT2i Nov 27 | 2018Invokana CANVAS promotion observed on patient and HCP websitesPurchase Blast
$599
Posted in: Glucose Monitoring Nov 21 | 2018Dexcom and Verily Update Agreement, Focus on T2DM MarketPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 20 | 2018Onduo Free Promotional Program; Insulet Dash Meets ISO StandardsPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 20 | 2018Medtronic CY Q3 '18 (FY Q2 '19) Earnings UpdatePurchase Blast$599
Posted in: Glucose Monitoring Nov 19 | 2018Verily/Novartis Halts Glucose Sensing Contact Lens DevelopmentPurchase Blast$599
Posted in: Glucagon Nov 15 | 2018Zealand Q3 '18 Earnings; Xeris Initiates New Ph3 Study vs. GlucaGenPurchase Blast
Free
Posted in: Other Nov 14 | 2018Amarin’s REDUCE-IT: Winners, Losers, and Suitors AnalysisAccess Free Blast